Lysosomal multienzyme complex: Pros and cons of working together

Cellular and Molecular Life Sciences

Volumn 71, Issue 11, 2014, Pages 2017-2032

  Bonten, Erik J ^a   Annunziata, Ida ^a   D'Azzo, Alessandra ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Elastin binding protein (EBP); Lysosomal exocytosis; Neuraminidase 1 (NEU1); Protective protein cathepsin A (PPCA); Sialic acid; Galactosidase ( GAL)

Indexed keywords

BETA GALACTOSIDE; CARBOXYPEPTIDASE C; CHAPERONE; LYSOSOME ENZYME; NEURAMINIDASE 1; SIALIDASE; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CELL SURFACE; EXOCYTOSIS; GALACTOSIALIDOSIS; GM1 GANGLIOSIDOSIS; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; LYSOSOME; LYSOSOME STORAGE DISEASE; METASTASIS; MOUSE MODEL; MUCOLIPIDOSIS TYPE 1; NERVE CELL NECROSIS; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR INVASION;

ANIMALS; BETA-GALACTOSIDASE; CATHEPSIN A; DISEASE MODELS, ANIMAL; GANGLIOSIDOSIS, GM1; GENE EXPRESSION REGULATION; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MICE; MICE, KNOCKOUT; MUCOLIPIDOSES; MULTIENZYME COMPLEXES; NEURAMINIDASE; SIGNAL TRANSDUCTION;

EID: 84901647945     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1538-3     Document Type: Review

References (100)

1. D'Azzo A, Hoogeveen A, Reuser AJ, Robinson D, Galjaard H (1982) Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA 79(15):4535-4539
2. Verheijen F, Brossmer R, Galjaard H (1982) Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex. Biochem Biophys Res Commun 108(2):868-875
3. Galjart NJ, Gillemans N, Harris A, van der Horst GT, Verheijen FW, Galjaard H, d'Azzo A (1988) Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell 54(6):755-764
4. Bonten EJ, Galjart NJ, Willemsen R, Usmany M, Vlak JM, d'Azzo A (1995) Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J Biol Chem 270(44):26441-26445
5. Pshezhetsky AV, Potier M (1996) Association of N-acetylgalactosamine-6- sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate. J Biol Chem 271(45):28359-28365
6. van der Spoel A, Bonten E, d'Azzo A (2000) Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme. J Biol Chem 275(14):10035-10040
7. Bonten EJ, d'Azzo A (2000) Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A. J Biol Chem 275(48):37657-37663
8. van der Spoel A, Bonten E, d'Azzo A (1998) Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J 17(6):1588-1597
9. Galjart NJ, Gillemans N, Harris A, van der Horst GTJ, Verheijen FW, Galjaard H, d'Azzo A (1988) Expression of cDNA encoding the human protective protein associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell 54:755-764
10. Jackman HL, Morris PW, Deddish PA, Skidgel RA, Erdos EG (1992) Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem 267(5):2872-2875
11. Hanna WL, Turbov JM, Jackman HL, Tan F, Froelich CJ (1994) Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase called cathepsin A-like protective protein. J Immunol 153(10):4663-4672
12. Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdos EG (2002) Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension 39(5):976-981
13. Rudenko G, Bonten E, d'Azzo A, Hol WG (1996) Structure determination of the human protective protein: twofold averaging reveals the three-dimensional structure of a domain which was entirely absent in the initial model. Acta Crystallogr D Biol Crystallogr 52(Pt 5):923-936
14. Rudenko G, Bonten E, d'Azzo A, Hol WG (1995) Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism. Structure 3(11):1249-1259
15. Bonten EJ, Campos Y, Zaitsev V, Nourse A, Waddell B, Lewis W, Taylor G, d'Azzo A (2009) Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization. J Biol Chem 284(41):28430-28441
16. Galjart NJ, Morreau H, Willemsen R, Gillemans N, Bonten EJ, d'Azzo A (1991) Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem 266(22):14754-14762
17. d'Azzo A, Andria G, Strisciuglio P, Galjaard H (2001) Galactosialidosis. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease, vol 3, 8th edn. McGraw-Hill Publishing Co., New York, pp 3811-3826
18. Thomas GH (2001) Disorders of glycoprotein degradation and structure: α-mannosidosis, β-mannosidosis, fucosidosis, and sialidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol III, 8th edn. McGraw Hill Inc., New York, pp 3507-3534
19. Suzuki YAO, Namba E (2001) β-Galactosidase deficiency (β-Galactosialidosis): GM1 gangliosidosis and morquio B disease. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Publishing Co, New York, pp 3775-3810
20. Caciotti A, Garman SC, Rivera-Colon Y, Procopio E, Catarzi S, Ferri L, Guido C, Martelli P, Parini R, Antuzzi D, Battini R, Sibilio M, Simonati A, Fontana E, Salviati A, Akinci G, Cereda C, Dionisi-Vici C, Deodato F, d'Amico A, d'Azzo A, Bertini E, Filocamo M, Scarpa M, di Rocco M, Tifft CJ, Ciani F, Gasperini S, Pasquini E, Guerrini R, Donati MA, Morrone A (2011) GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta 1812(7):782-790
21. Caciotti A, Catarzi S, Tonin R, Lugli L, Perez CR, Michelakakis H, Mavridou I, Donati MA, Guerrini R, d'Azzo A, Morrone A (2013) Galactosialidosis: review and analysis of CTSA gene mutations. Orphanet J Rare Dis 8:114
22. d'Azzo A, Bonten E (2010) Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease. Biochem Soc Trans 38(6):1453-1457
23. de Geest N, Bonten E, Mann L, de Sousa-Hitzler J, Hahn C, d'Azzo A (2002) Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 11(12):1455-1464
24. Zhou XY, Morreau H, Rottier R, Davis D, Bonten E, Gillemans N, Wenger D, Grosveld FG, Doherty P, Suzuki K, Grosveld GC, d'Azzo A (1995) Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with over-expressing erythroid precursor cells. Genes Dev 9:2623-2634
25. Rottier RJ, Hahn CN, Mann LW, del Pilar Martin M, Smeyne RJ, Suzuki K, d'Azzo A (1998) Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Hum Mol Genet 7(11):1787-1794 (pii: ddb219)
26. Jackman HL, Tan FL, Tamei H, Beurling-Harbury C, Li XY, Skidgel RA, Erdos EG (1990) A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein". J Biol Chem 265(19):11265-11272
27. Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y, Canuel M, Itoh K, Morales CR, Lavoie J, Tremblay J, Pshezhetsky AV (2008) Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 117(15):1973-1981
28. Monti E, Bassi MT, Bresciani R, Civini S, Croci GL, Papini N, Riboni M, Zanchetti G, Ballabio A, Preti A, Tettamanti G, Venerando B, Borsani G (2004) Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics 83(3):445-453
29. Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B, Croci G, Preti A, Ballabio A, Tettamanti G, Borsani G (2000) Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J 349(Pt 1):343-351
30. Monti E, Bonten E, D'Azzo A, Bresciani R, Venerando B, Borsani G, Schauer R, Tettamanti G (2010) Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 64:403-479
31. Monti E, Preti A, Rossi E, Ballabio A, Borsani G (1999) Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics 57(1):137-143
32. Hahn CN, del Pilar Martin M, Schroder M, Vanier MT, Hara Y, Suzuki K, d'Azzo A (1997) Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Hum Mol Genet 6(2):205-211
33. Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126(Pt 4):974-987
34. Wang D, Bonten EJ, Yogalingam G, Mann L, d'Azzo A (2005) Short-term, high dose enzyme replacement therapy in sialidosis mice. Mol Genet Metab 85(3):181-189
35. Baek RC, Broekman ML, Leroy SG, Tierney LA, Sandberg MA, d'Azzo A, Seyfried TN, Sena-Esteves M (2010) AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival. PLoS ONE 5(10):e13468
36. Bonten EJ, Wang D, Toy JN, Mann L, Mignardot A, Yogalingam G, d'Azzo A (2004) Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis. FASEB J 18(9):971-973
37. Bonten EJ, Yogalingam G, Hu H, Gomero E, van de Vlekkert D, d'Azzo A (2013) Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis. Biochim Biophys Acta 1832(10):1784-1792
38. Elliot-Smith E, Speak AO, Lloyd-Evans E, Smith DA, van der Spoel AC, Jeyakumar M, Butters TD, Dwek RA, d'Azzo A, Platt FM (2008) Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. Mol Genet Metab 94(2):204-211
39. Hu H, Gomero E, Bonten E, Gray JT, Allay J, Wu Y, Wu J, Calabrese C, Nienhuis A, d'Azzo A (2012) Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis. Mol Ther 20(2):267-274
40. Kasperzyk JL, d'Azzo A, Platt FM, Alroy J, Seyfried TN (2005) Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. J Lipid Res 46(4):744-751
41. Kasperzyk JL, El-Abbadi MM, Hauser EC, d'Azzo A, Platt FM, Seyfried TN (2004) N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. J Neurochem 89(3):645-653
42. Leimig T, Mann L, Martin Mdel P, Bonten E, Persons D, Knowles J, Allay JA, Cunningham J, Nienhuis AW, Smeyne R, d'Azzo A (2002) Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells. Blood 99(9):3169-3178
43. Sano R, Tessitore A, Ingrassia A, d'Azzo A (2005) Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology. Blood 106(7):2259-2268
44. Cuervo AM, Mann L, Bonten EJ, d'Azzo A, Dice JF (2003) Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J 22(1):47-59
45. Lichter-Konecki U, Moter SE, Krawisz BR, Schlotter M, Hipke C, Konecki DS (1999) Expression patterns of murine lysosome-associated membrane protein 2 (Lamp-2) transcripts during morphogenesis. Differentiation 65(1):43-58
46. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P (2000) Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406(6798):902-906
47. Cuervo AM, Dice JF (1996) A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273(5274):501-503
48. Arias E, Cuervo AM (2011) Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 23(2):184-189
49. Kaushik S, Cuervo AM (2012) Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22(8):407-417
50. Cuervo AM, Dice JF (2000) Regulation of lamp2a levels in the lysosomal membrane. Traffic 1(7):570-583
51. Bossi G, Griffiths GM (2005) CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol 17(1):87-94
52. Andrews NW (2000) Regulated secretion of conventional lysosomes. Trends Cell Biol 10(8):316-321
53. Bossi G, Booth S, Clark R, Davis EG, Liesner R, Richards K, Starcevic M, Stinchcombe J, Trambas C, Dell'Angelica EC, Griffiths GM (2005) Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XV. Traffic 6(3):243-251
54. Yogalingam G, Bonten EJ, van de Vlekkert D, Hu H, Moshiach S, Connell SA, d'Azzo A (2008) Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 15(1):74-86
55. Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305(5680):55-59
56. Kima PE, Burleigh B, Andrews NW (2000) Surface-targeted lysosomal membrane glycoprotein-1 (Lamp-1) enhances lysosome exocytosis and cell invasion by Trypanosoma cruzi. Cell Microbiol 2(6):477-486
57. Zanoteli E, van de Vlekkert D, Bonten EJ, Hu H, Mann L, Gomero EM, Harris AJ, Ghersi G, d'Azzo A (2010) Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue. Biochim Biophys Acta 1802(7-8):659-672
58. Wu X, Steigelman KA, Bonten E, Hu H, He W, Ren T, Zuo J, d'Azzo A (2010) Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice. Biochim Biophys Acta 1802(2):259-268
59. Hinek A, Bodnaruk TD, Bunda S, Wang Y, Liu K (2008) Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2. Am J Pathol 173(4):1042-1056
60. Hinek A, Rabinovitch M, Keeley F, Okamura-Oho Y, Callahan J (1993) The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest 91(3):1198-1205
61. Morreau H, Galjart NJ, Gillemans N, Willemsen R, van der Horst GT, d'Azzo A (1989) Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem 264(34):20655-20663
62. Blanchevoye C, Floquet N, Scandolera A, Baud S, Maurice P, Bocquet O, Blaise S, Ghoneim C, Cantarelli B, Delacoux F, Dauchez M, Efremov RG, Martiny L, Duca L, Debelle L (2013) Interaction between the elastin peptide VGVAPG and human elastin binding protein. J Biol Chem 288(2):1317-1328
63. Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B (2006) Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem 281(6):3698-3710
64. Lehman A, Mattman A, Sin D, Pare P, Zong Z, d'Azzo A, Campos Y, Sirrs S, Hinek A (2012) Emphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assembly. Mol Genet Metab 106(1):99-103
65. Starcher B, d'Azzo A, Keller PW, Rao GK, Nadarajah D, Hinek A (2008) Neuraminidase-1 is required for the normal assembly of elastic fibers. Am J Physiol Lung Cell Mol Physiol 295(4):L637-L647
66. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, Tokuyama S, Sawada M (1999) Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem 274(8):5004-5011
67. Arabkhari M, Bunda S, Wang Y, Wang A, Pshezhetsky AV, Hinek A (2010) Desialylation of insulin receptors and IGF-1 receptors by neuraminidase-1 controls the net proliferative response of L6 myoblasts to insulin. Glycobiology 20(5):603-616
68. Dridi L, Seyrantepe V, Fougerat A, Pan X, Bonneil E, Thibault P, Moreau A, Mitchell GA, Heveker N, Cairo CW, Issad T, Hinek A, Pshezhetsky AV (2013) Positive regulation of insulin signaling by neuraminidase 1. Diabetes 62(7):2338-2346
69. Shi J, Wang A, Sen S, Wang Y, Kim HJ, Mitts TF, Hinek A (2012) Insulin induces production of new elastin in cultures of human aortic smooth muscle cells. Am J pathol 180(2):715-726
70. Liang F, Seyrantepe V, Landry K, Ahmad R, Ahmad A, Stamatos NM, Pshezhetsky AV (2006) Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. J Biol Chem 281(37):27526-27538
71. Stamatos NM, Carubelli I, van de Vlekkert D, Bonten EJ, Papini N, Feng C, Venerando B, d'Azzo A, Cross AS, Wang LX, Gomatos PJ (2010) LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J Leukoc Biol 88(6):1227-1239
72. Feng C, Stamatos NM, Dragan AI, Medvedev A, Whitford M, Zhang L, Song C, Rallabhandi P, Cole L, Nhu QM, Vogel SN, Geddes CD, Cross AS (2012) Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex. PLoS ONE 7(4):e32359
73. Nan X, Carubelli I, Stamatos NM (2007) Sialidase expression in activated human T lymphocytes influences production of IFN-gamma. J Leukoc Biol 81(1):284-296
74. Amith SR, Jayanth P, Franchuk S, Siddiqui S, Seyrantepe V, Gee K, Basta S, Beyaert R, Pshezhetsky AV, Szewczuk MR (2009) Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase. Glycoconj J 26(9):1197-1212
75. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, Pshezhetsky AV, Szewczuk MR (2010) Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal 22(2):314-324
76. Abdulkhalek S, Amith SR, Franchuk SL, Jayanth P, Guo M, Finlay T, Gilmour A, Guzzo C, Gee K, Beyaert R, Szewczuk MR (2011) Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling. J Biol Chem 286(42):36532-36549
77. Lillehoj EP, Hyun SW, Feng C, Zhang L, Liu A, Guang W, Nguyen C, Luzina IG, Atamas SP, Passaniti A, Twaddell WS, Puche AC, Wang LX, Cross AS, Goldblum SE (2012) NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. J Biol Chem 287(11):8214-8231
78. Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M (2012) Mechanisms of cancer-associated glycosylation changes. Front Biosci (Landmark Ed) 17:670-699
79. Adamczyk B, Tharmalingam T, Rudd PM (2011) Glycans as cancer biomarkers. Biochim Biophys Acta 1820(9):134
80. Harduin-Lepers A, Krzewinski-Recchi MA, Colomb F, Foulquier F, Groux-Degroote S, Delannoy P (2012) Sialyltransferases functions in cancers. Front Biosci (Elite Ed) 4:499-515
81. Miyagi T, Wada T, Yamaguchi K, Shiozaki K, Sato I, Kakugawa Y, Yamanami H, Fujiya T (2008) Human sialidase as a cancer marker. Proteomics 8(16):3303-3311
82. Uemura T, Shiozaki K, Yamaguchi K, Miyazaki S, Satomi S, Kato K, Sakuraba H, Miyagi T (2009) Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. Oncogene 28(9):1218-1229
83. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, Miyagi T (2007) A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 26(17):2483-2490
84. Tessitore A, del Pilar Martin M, Sano R, Ma Y, Mann L, Ingrassia A, Laywell ED, Steindler DA, Hendershot LM, d'Azzo A (2004) GM1-ganglioside- mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell 15(5):753-766
85. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13(10):1211-1233
86. Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101(5):451-454
87. Ma Y, Hendershot LM (2001) The unfolding tale of the unfolded protein response. Cell 107(7):827-830
88. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453):664-666
89. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403(6765):98-103
90. Vance JE (1990) Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 265(13):7248-7256
91. Ardail D, Popa I, Bodennec J, Louisot P, Schmitt D, Portoukalian J (2003) The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. Biochem J 371:1013-1019
92. Bionda C, Portoukalian J, Schmitt D, Rodriguez-Lafrasse C, Ardail D (2004) Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem J 382:527-533
93. Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J, Forte M, d'Azzo A (2009) GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis. Mol Cell 36(3):500-511
94. de Brito OM, Scorrano L (2008) Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456(7222):605-610
95. Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, Nagy AI, Balla T, Rizzuto R (2006) Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol 175:901-911
96. Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596-610
97. Rizzuto R, Brini M, Murgia M, Pozzan T (1993) Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262:744-747
98. Ledeen RW, Wu G (2002) Ganglioside function in calcium homeostasis and signaling. Neurochem Res 27(7-8):637-647
99. Ledeen RW, Wu G (2006) GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium-calcium exchanger. Can J Physiol Pharmacol 84:393-402
100. Annunziata I, Patterson A, Helton D, Hu H, Moshiach S, Gomero E, Nixon R, d'Azzo A (2013) Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis. Nature Commun. doi: 10.1038/ncomms3734